BioCryst Pharmaceuticals
BCRX
BCRX
100 hedge funds and large institutions have $147M invested in BioCryst Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 21 closing their positions.
Holders
100
Holders Change
-9
Holders Change %
-8.26%
% of All Funds
2.67%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
12
Increased
32
Reduced
31
Closed
21
Calls
$262K
Puts
$62K
Net Calls
+$200K
Net Calls Change
+$125K
Top Buyers
1 |
GTC
1
Ghost Tree Capital
New York
|
$4.83M |
2 |
VMI
2
VHCP Management II
New York
|
$16.2M |
3 |
VM
3
VHCP Management
New York
|
$2.85M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$10M |
5 |
RI
5
RTW Investments
New York
|
$6.35M |